Passionate about IP! Since June 2003 the IPKat has covered copyright, patent, trade mark, designs, info-tech and confidentiality issues from a mainly UK and European perspective. Read, post comments and participate!

The team is Eleonora Rosati, Annsley Merelle Ward and Merpel. E-mail the Kats here!

The team is joined by GuestKats Söğüt Atilla, Oliver Fairhurst, Claire Gregg, Georgia Jenkins and Marcel Pemsel.

SpecialKats: Verónica Rodríguez Arguijo (TechieKat), Rose Hughes (PatKat) and Jocelyn Bosse (Book Review Editor).

InternKats: Wissam Bentazar, Simone Lorenzi and Kliment Markov.
Results for Hospira
The English approach to obviousness - It all depends on the facts? The English approach to obviousness - It all depends on the facts? Reviewed by Darren Smyth on Thursday, September 22, 2016 Rating: 5
What the pH? A closer look at Hospira v Cubist and daptomycin micelles What the pH? A closer look at Hospira v Cubist and daptomycin micelles Reviewed by Darren Smyth on Friday, September 02, 2016 Rating: 5
Hospira v Genentech - revocation of patents confirmed on appeal Hospira v Genentech - revocation of patents confirmed on appeal Reviewed by Darren Smyth on Friday, July 29, 2016 Rating: 5
Letter from AmeriKat: Hospira's Angiomax win, Apple jury award vacated & Obama's Pacific trade deal Letter from AmeriKat: Hospira's Angiomax win, Apple jury award vacated & Obama's Pacific trade deal Reviewed by Annsley Merelle Ward on Sunday, July 12, 2015 Rating: 5
Patent Déjà vu - Hospira v Genentech and another patent dies Patent Déjà vu - Hospira v Genentech and another patent dies Reviewed by Darren Smyth on Tuesday, June 30, 2015 Rating: 5
Hospira v Genentech Mark 1, the Appeal Hospira v Genentech Mark 1, the Appeal Reviewed by Darren Smyth on Friday, February 06, 2015 Rating: 5
Hurray for judicial sense on product by process claims - Birss triumphs in Hospira v Genentech Hurray for judicial sense on product by process claims - Birss triumphs in Hospira v Genentech Reviewed by Darren Smyth on Wednesday, December 10, 2014 Rating: 5
UPDATE: Birss J refuses permission to appeal in Genentech's Herceptin battle UPDATE: Birss J refuses permission to appeal in Genentech's Herceptin battle Reviewed by Annsley Merelle Ward on Friday, May 23, 2014 Rating: 5
Another two bite the dust – Hospira v Genentech Another two bite the dust – Hospira v Genentech Reviewed by Darren Smyth on Monday, April 14, 2014 Rating: 5
Sanofi Aventis Taxotere Patents invalidated by CAFC Sanofi Aventis Taxotere Patents invalidated by CAFC Reviewed by Darren Smyth on Tuesday, April 10, 2012 Rating: 5
Subscribe to: Posts ( Atom )
Powered by Blogger.